(P-1487) Respiratory syncytial virus (RSV) vaccination in adults aged <60 years at increased risk of severe RSV disease: considerations of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Co-Author(s)

Michael Melgar, MD (he/him/his)

Medical Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States

Amadea Britton, MD, SM

Medical Officer, Co-Lead ACIP Adult RSV Work Group
Centers for Disease Control and Prevention
Atlanta, GA, United States
DS

Diya Surie, MD

Medical Officer
Centers for Disease Control and Prevention
Atlanta, GA, United States
MG

Monica Godfrey, MPH, CHES

Centers for Disease Control and Prevention
Atlanta, Georgia, United States
RL

Ruth Link-Gelles, PhD, MPH

Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Fiona P. Havers, MD (she/her/hers)

Team Lead (acting), RESP-NET Surveillance Team
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Meredith L. McMorrow, MD, MPH (she/her/hers)

Acting Branch Chief
CDC/NCIRD/CORVD/SPB
Atlanta, GA, United States
Mini Kamboj, MD

CHIEF MEDICAL EPIDEMIOLOGIST
MSKCC
New York, NY, United States
Helen Y. Chu, MD, MPH

Professor
University of Washington
Seattle, WA, United States
Keipp Talbot, MD MPH

Infectious Diseases Physician
Vanderbilt University Medical Center
Nashville, Tennessee, United States